Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation programme

Prioritisation programme

Decision

Decision

Showing 1 to 50 of 386

TitlePrioritisation programmeDecisionDecision date
Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma in people aged 12 to 17 [TSID11839]Medicines evaluationNot selected
Peginterferon alfa-2a for treating polycythaemia vera or essential thrombocythaemia [TSID12325]Medicines evaluationNot selected
Dronabinol for treating muscle spasticity in multiple sclerosis after 2 treatments [TSID10638]Medicines evaluationNot selected
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (managed access review of TA1023) [ID6653]None selectedAwaiting decision
Dabrafenib for treating unresectable or metastatic BRAF V600 mutation positive melanoma in people 12 to 17 years [TSID12399]Medicines evaluationNot selected
Dabrafenib with trametinib for treating unresectable or metastatic BRAF V600 mutation positive melanoma in people 12 to 17 years [TSID12398]Medicines evaluationNot selected
Wireless breast lesion localization using Savi Scout seedInterventional proceduresAwaiting decision
CT hepatic arteriography for patients undergoing percutaneous ablation of primary or secondary liver tumoursInterventional proceduresAwaiting decision
Ponatinib for treating recurrent or refractory chronic myeloid leukaemia in people 1 to 17 years when another tyrosine kinase inhibitor is unsuitable [TSID12041]Medicines evaluationNot selected
Vedolizumab for treating moderately to severely active Crohn's disease in people 2 to 17 years [TSID12312]Medicines evaluationNot selected
Isavuconazol for treating invasive aspergillosis or mucormycosis in people 1 to 17 years [TSID12284]Medicines evaluationNot selected
SEEG-guided radiofrequency thermocoagulation in refractory epilepsyInterventional proceduresAwaiting decision
Subcutaneous olanzapine for treating schizophrenia [TSID12289]Medicines evaluationNot selected
Menotrophin prefilled pen for treating anovulation or during controlled ovarian hyperstimulation [TSID12290]Medicines evaluationNot selected
Ciclosporin (Vevizye) eye drops for treating moderate to severe keratoconjunctivitis [TSID12293]Medicines evaluationNot selected
Xeomin (botulinum neurotoxin type A) for treating lower or upper limb spasticity in people 2 to 17 years [TSID12297]None selectedNot selected
Gilteritinib + daunorubicin + cytarabine for Acute myeloid leukaemia (AML) [TSID12331]None selectedAwaiting decision
Epcoritamab + R-CHOP for Diffuse large B-cell lymphoma (DLBCL) [TSID12334]None selectedAwaiting decision
Transverse Tibial TransportInterventional proceduresAwaiting decision
Lanadelumab for preventing recurrent attacks of hereditary angioedema in people 2 years and over [TSID12298]None selectedNot selected
Ivacaftor–tezacaftor–elaxcaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in people 1 to under 2 years [TSID12295]None selectedNot selected
Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more responsive mutations in the CFTR gene in people 2 to 5 years [TSID12296]None selectedNot selected
Thermal Probe Ablation for abdominal wall endometriosisNone selectedAwaiting decision
Sentinel Node Biopsy approved for pathological staging of clinically T1-T2 N0 oral cancerNone selectedNot selected
Vacuum Assisted Excision for the removal of breast lesions of uncertain malignant potentialHealthTechNot selected
Mercaptamine hydrochloride for treating corneal cystine crystal deposits in people 6 months to under 2 years with cystinosis [TSID12261]None selectedNot selected
Digital flexor tenotomy for diabetic footNone selectedAwaiting decision
Omental lymph node transfer for lymphoedema of the limbsNone selectedAwaiting decision
Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249]None selectedNot selected
Modified release hydrocortisone capsules for treating adrenal insufficiency in people 12 years and over [TSID12254]None selectedNot selected
Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years [TSID12255]None selectedNot selected
Male sling for stress urinary incontinenceNone selectedNot selected
Technologies to improve the detection of endometrial cancerNone selectedAwaiting decision
Dermal allograft augmentation in proximal humerus fracture fixationNone selectedAwaiting decision
Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA)None selectedAwaiting decision
Hip resurfacing for hip arthritisNone selectedAwaiting decision
Cryoablation for Desmoid-type FibromatosisHealthTechAwaiting decision
Transarterial radio embolisation for osteosarcoma liver metastasesHealthTechAwaiting decision
Ferric citrate for managing iron and serum phosphorus levels in anaemia associated with chronic kidney disease [TSID12221]None selectedNot selected
Cardiac ablation with percutaneous left atrial appendage occlusion (LAAO) for atrial fibrillationNone selectedAwaiting decision
Intradiscal Platelet Rich Plasma (PRP) Injections for Back Pain with Modic Type 1 ChangesNone selectedAwaiting decision
Robotic surgery for paediatric populationNone selectedNot selected
Bioinductive collagen scaffold (Regeneten) for rotator cuf repairNone selectedNot selected
Orbital atherectomy for calcified coronary artery diseaseNone selectedNot selected
NeuroSAFE for Intra-operative frozen section evaluation of neurovascular bundle adjacent prostate capsule during radical prostatectomyNone selectedAwaiting decision
Zanubrutinib for Chronic lymphocytic leukaemia (CLL) or Follicular lymphoma or Marginal zone lymphoma (MZL) or Waldenstrom's macroglobulinaemia [ID12199]None selectedNot selected
Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung cancer [TSID12213]None selectedNot selected
Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214]None selectedNot selected
Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219]None selectedNot selected
Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All